• 1
    Järemo P, Hansson G, Nilsson O. Elevated inflammatory parameters are associated with lower platelet density in acute myocardial infarctions with ST-elevation. Thromb Res 2000; 100: 4718.
  • 2
    Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy – I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81106.
  • 3
    Sharis PJ, Cannon CP, Loscalzo J. The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med 1998; 129: 394405.
  • 4
    Bertrand ME, Rupprecht HJ, Urban P, Gershlick AH for the CLASSICS investigators. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting. Circulation 2000; 102: 6249.
  • 5
    Taniuchi M, Kurz HI, Lasala JM. Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population. Circulation 2001; 104: 5393.
  • 6
    Savcic M, Hauert J, Bachmann F, Wyld PJ, Geudelin B, Cariou R. Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects. Semin Thromb Hemost 1999; 25 (Suppl. 2): 159.
  • 7
    Järemo P, Lindahl TL, Milovanovic M, Logander E, Fransson SG, Richter A. Inverse relationship between platelet density and reactivity at coronary angiography. Haemostasis 2001; 31: 5560.
  • 8
    Forbes CD, Lowe GDO, MacLaren M, Shaw BG, Dickinson JP, Kieffer G. Clopidogrel compatibility with concomitant cardiac co-medications: a study of its interactions with a beta-blocker and a calcium uptake antagonist. Semin Thromb Hemost 1999; 25 (Suppl. 2): 559.
  • 9
    McEwen J, Strauch G, Perles P et al. Clopidogrel bioavailability: absence of influence of food or antacidas. Semin Thromb Hemost 1999; 25 (Suppl. 2): 4750.
  • 10
    Langford EJ, Wainwright RJ, Martin JF. Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors. Atherioscler Thromb Vasc Biol 1996; 16: 515.
  • 11
    Seyfarth HJ, Koksch M, Roethig G et al. Effect of 300- and 450-mg clopidogrel loading doses on membrane and soluble P-selectin in patients undergoing coronary stent implantation. Am Heart J 2002; 143: 11823.
  • 12
    Gamble JR, Skinner MP, Berndt MC, Vadas MA. Prevention of activated neutrophil adhesion to endothelium by soluble adhesion protein GMP 140. Science 1990; 249: 4147.
  • 13
    Topol EJ. The future of antiplatelet therapy: optimising management in patients with acute coronary syndrome. Clin Cardiol 2000; 23 (Suppl. 6): 238.